VEGFA and diabetic retinopathy: The stability of VD throughout anti-VEGF therapy suggests that this treatment approach may be helpful for patients with macular nonperfusion, which is worthy of mention because nonperfusion is presumed to worsen in individuals with diabetic retinopathy.[20,29]